NEW YORK (GenomeWeb News) – Takara Bio said Monday that it has signed an agreement to offer Pathogenica's HAI BioDetection Kit in Japan as part of its sequencing services.
The sequencing-based kit enables identification of hospital acquired infections with a turnaround of less than 12 hours. According to Takara, the kit identifies what species are present in a sample and provides sequence data, including strain identity and resistance genes. Specifically, it can detect 12 bacteria commonly associated with HAIs and 15 resistance gene families in a single assay, and it can process 12 samples per sequencing run.
Shiga, Japan-based Takara Bio noted that the Pathogenica HAI BioDetection Kit is for research use only.
The firm also offers sequencing services through its Dragon Genomics Center.
Financial and other terms of the agreement were not disclosed.
Earlier this year Pathogenica signed an agreement with Life Technologies to distribute the test in Japan on the Ion Torrent platform.